The DOI matches its Crossref record.
Association between Polycystic Ovaries and Extent of Coronary Artery Disease in Women Having Cardiac Catheterization
Abstract
BACKGROUND: Women with polycystic ovaries have associated risk factors for coronary artery disease. It is unknown whether women with more extensive coronary artery disease are more likely to have polycystic ovaries. OBJECTIVE: To determine whether women who have more extensive coronary artery disease as seen on coronary angiography are more likely to have polycystic ovaries appearing on ultrasonography than are women with less severe coronary disease. DESIGN: Prevalence study of women who had had coronary angiography. SETTING: Women referred for coronary angiography for assessment of chest pain or valvular disease in Auckland, New Zealand, during a 2-year period. PATIENTS: 143 women 60 years of age or younger who had had coronary angiography. Women who had previously had bilateral oophorectomy were excluded. MEASUREMENTS: The extent of coronary artery disease assessed by quantitative angiography was compared with the presence or absence of polycystic ovaries. Pelvic ultrasonography was done without knowledge of the extent of coronary artery disease. Assessment of angiograms was blinded. Insulin resistance and gonadotropin, testosterone, and serum lipid levels were also measured. RESULTS: Polycystic ovaries were found in 42% of women and were associated with hirsutism; previous hysterectomy; higher free testosterone, triglyceride, and C-peptide levels; and lower high-density lipoprotein cholesterol levels. Women with polycystic ovaries had more extensive coronary artery disease than women with normal ovaries (number of segments with > 50% stenosis, 1.7 [95% CI, 1.1 to 2.3] compared with 0.82 [CI, 0.54 to 1.1]; P < 0.01). On logistic regression analysis, the extent of coronary artery disease (P = 0.032) and family history of heart disease (P = 0.022) were predictors of the presence of polycystic ovaries. CONCLUSIONS: In women having coronary angiography, those with more extensive coronary artery disease were more likely to have polycystic ovaries on ultrasonography than were those with less extensive disease. Visualization of polycystic ovaries by sonography was associated with distinct metabolic and endocrine abnormalities. Further study is required to evaluate whether surgery or hormone replacement therapy can modify the risk.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In PCOS, other novel CVD risk factors, premature cardiovascular dysfunction and subclinical CVD 29,30,83 have been noted and are related to IR and obesity. 84-89”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [87]
Citations
Cited by
Sorted by citations
Items 301–328 of 328
MECHANISMS OF CARDIOVASCULAR DISEASE RISKS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
Studen, K. B., Preželj, J., Kocjan, T., & Pfeifer, M. (2009) · DOAJ (DOAJ: Directory of Open Access Journals)
Baykara, M., & Gökçe, C. (2012) · Annals of Medical Research · doi:10.7247/jiumf.19.2.4
Síndrome metabólico (Segunda Parte)
Isaac Crespo, R., Iván Odórico Belzusarri, P., & Aldo Stucchi, G. (2006) · Horizonte Médico (Lima) · doi:10.24265/horizmed.2006.v6n2.07
METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY
Alebić, M. Š., & Duvnjak, L. S. (2010) · Diabetologia Croatica
Menstrual cycles, vasomotor symptoms, hormone therapy and risk of cardiovascular disease
Herber-Gast, G.-C. M. (2010) · Utrecht University Repository (Utrecht University)
Síndrome de ovario poliquístico y enfermedad cardiovascular
Escalada, J. (2005) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(05)71021-4
von der Lohe, E. (2002) · Springer eBooks · doi:10.1007/978-3-642-56041-5_2
Ovaires micropolykystiques et syndrome d’insulinorésistance
LORCY, Y. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)81683-x
“Dans une autre étude [10] où le diagnostic de SOPK était basé sur des critères échographiques, une sténose coronarienne était retrouvée dans 50 % des cas.”
Cameroon, M., Ethiopia, M., Malawi, M., South Africa, M., & Tanzania, M. (2009)
Polycystic Ovary Syndrome, Insulin Resistance and Cardiovascular Disease
Corcoran, M. H., & Ehrmann, D. A. (2002) · CRC Press eBooks · doi:10.1201/b14062-10
Detection and Diagnosis of Heart Disease in Diabetic and Prediabetic Subjects
Thanigaraj, S., & Pérez, J. E. (2002) · CRC Press eBooks · doi:10.1201/b14062-11
Polycystic Ovary Syndrome and the Climacteric: Metabolic Consequences and Management
Rajkhowa, M., & Balen, A. H. (1999) · The Journal of the British Menopause Society · doi:10.1177/136218079900500208
New routes in the polycystic ovary syndrome labyrinth
Moghetti, P., & Castello, R. (1998)
Dietary management of Polycystic ovary syndrome.
Moran, L. (2007) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Hormontherapie der KHK bei Frauen: Kardioprotektion oder Risiko?
Gohlke-Bärwolf, C. (2002) · Steinkopff eBooks · doi:10.1007/978-3-642-57534-1_11
Polycystic ovary syndrome - Metformin treatment in pregnancy
Vanky, E. (2005) · NORA - Norwegian Open Research Archives
Arterial wall mechanics in women with polycystic ovary syndrome.
Lakhani, K. (2005) · UCL Discovery (University College London)
TUXUMDON POLIKISTOZIDA ULTRATOVUSH TEKSHIRISHNING AHAMIYATI
Xodjibekova, Y., & Axmedova, N. (2024) · MedicineProblems uz-Topical Issues of Medical Sciences · doi:10.47390/3030-3133v1i2y2023n01
(2000) · Time to knit · doi:10.1016/s1047-9422(03)00084-1
(2000) · Time to knit · doi:10.1016/s1047-9422(02)00058-5
Recommended Therapies for Metabolic Defects in Polycystic Ovary Syndrome
Norman, R. J., Ruifrok, A. E., Moran, L., & Robker, R. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_16
Loucks, T. L. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Polycystic Ovary Syndrome and the Metabolic Syndrome Long-Term Risks
Dahlgren, E., & Janson, P. O. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_12
Role of Estrogens in Vascular Disease in Diabetes
Tsatsoulis, A. A., & Economides, P. A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-908-7:129
Metadata
- Authors
- Birdsall, M. A., Farquhar, C. M., & White, H. D.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Birdsall, Mary A.
- ORCID
- White, Harvey D.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1997-01-01
- Volume
- 126
- Issue
- 1
- Pages
- 32-35
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1964741472
- Cited by
- 327
- References
- 0
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 6 · 2017: 2 · 2016: 7 · 2015: 15 · 2014: 2 · 2013: 9 · 2012: 11
- FWCI
- 12.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- polycystic ovary syndrome, coronary artery disease, women, coronary angiography, coronary stenosis extent, hirsutism, free testosterone, insulin resistance, triglycerides, C-peptide, HDL cholesterol, family history of heart disease
- MeSH terms
- Adult, Analysis of Variance, Coronary Disease, Female, Cardiac Catheterization, Humans, Middle Aged, Polycystic Ovary Syndrome, Prospective Studies, Ultrasonography, Coronary Angiography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review